BUY INNOVATIONQ+

Accelerate Innovation

throughout your organization’s departments & teams

Our innovation consulting team unites industry-leading expertise with premier patent software and solutions to provide the most comprehensive innovation consulting services available for your business. Using our IP Suite, we work with you to analyze complex problems, develop new ideas, map them to understand novelty and create an in-depth landscape report.

Unlock more Freedom to Innovate with Professional Services from IP.com

How we deliver is just as important as what we offer. When you choose IP.com, you can trust that you’re working with a team of vetted, highly qualified subject matter experts. We provide the industry depth and expertise you need, with certainty and confidentiality.

COnsulting Services

Our Consulting Methodology

IP.com’s Enterprise Innovation Consulting Services facilitate one- and two-day onsite sessions, working with R&D teams to provide an end-to-end solution. Our consulting methodology results in invigorating innovation and the achievement of a set of new actionable ideas for further exploration.

Our Tools & Solutions

We utilize a set of our patented AI-based tools to analyze existing solutions or complex technical problems, develop new solutions and ideas, map them to understand novelty, and develop an in-depth technology landscape report. The innovation consulting team prepares the entire agenda, guides the use of tools within your team, provides on-site instruction, and delivers results in a formal review.

Ready to get started?

COntact us to see how sERVICES from IP.COm® can enhance your innovation workflow

15 + 15 =

PATENT News & Resources
How Apple, the Largest Company in the World, Plays the Patent Infringement Gamble

How Apple, the Largest Company in the World, Plays the Patent Infringement Gamble

In recent news, Apple has faced a patent infringement suit regarding the blood oxygen technology in two of its Apple Watch Series models resulting in a halt in sales of their watch models. The halt in sales comes after the International Trade Commission ruled that these two models’ use of blood oxygen tracking violated a patent from health technology company Masimo.

read more